Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLC599 PK Study in Knee Osteoarthritis
NCT03754049Phase 2Completed
- Sponsor
- Taiwan Liposome Company
- Start
- Jan 2019
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of TLC599 in osteoarthritis (OA), sponsored by Taiwan Liposome Company. Started Jan 2019; status: completed.
02
Drugs
TLC599
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03754049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03754049.